Rare Diseases and Genetic Disorders Peptide therapeutics have shown particular promise in treating rare diseases where traditional drug development may be economically challenging
Studies published in 2024 reveal that inositol supplementation helps ameliorate abnormal liver fat metabolism and supports hepatic cellular repair mechanisms, making it a vital ingredient to round out the detoxification process [5] (Zhang et al., 2024)
In standard scientific practice, a researcher with a patent and a company tied to their research subject would be required to declare that conflict
While GHK-Cu (with certain limitations) and L-Theanine have now been included on to the Category 1 bulks list, various peptides were added to the Category 2 bulk drug substance list (those that raise significant safety concerns)
PubMed Central , Clinical, Cosmetic and Investigational Dermatology , vol
10.1146/annurev-bioeng-071516-044546 317 YangM.VousdenK